Inhibiting the type 2 inflammatory pathway with dupilumab is associated with an increase in interleukin‐4 and interleukin‐18 production
Morris, Jymirah, Olonisakin, Tolani F., Moore, John A., Phan, BaDoi, Parker, Dana M., Uribe, Bliss A., Barel, Stephanie J., Bowers, Eve M.R., Buchheit, Kathleen M., Laidlaw, Tanya M., Lee, Stella E.
Published in International forum of allergy & rhinology (01.10.2022)
Published in International forum of allergy & rhinology (01.10.2022)
Get full text
Journal Article
Fractional Exhaled Nitric Oxide as a Marker of Mucosal Inflammation in Chronic Rhinosinusitis
Olonisakin, Tolani F, Moore, John A, Barel, Stephanie, Uribe, Bliss, Parker, Dana, Bowers, Eve M R, Nouraie, Seyed M, Wenzel, Sally E, Lee, Stella E
Published in American journal of rhinology & allergy (01.07.2022)
Published in American journal of rhinology & allergy (01.07.2022)
Get more information
Journal Article